ClinicalTrials.Veeva

Menu

Metabolic Effects of Choline and Docosahexaenoic Acid Supplementation in Preterm Infants

U

University Hospital Tuebingen

Status

Completed

Conditions

Infant, Premature

Treatments

Dietary Supplement: DHA supplementation
Dietary Supplement: standard nutrition
Dietary Supplement: choline supplementation

Study type

Interventional

Funder types

Other

Identifiers

NCT02509728
Choline and DHA for Preemies 2

Details and patient eligibility

About

To explore the effects of enteral choline and DHA supplementation on plasma choline and DHA-PC concentrations and metabolism, this randomized controlled study will assign 40 preterm infants to 1 of 4 groups: standard care, choline supplementation, DHA supplementation, and choline and DHA supplementation.

After 7 days of supplementation, a single dose of stable isotope labelled choline will be administered and the kinetics of newly synthesized DHA-PC determined to assess plasma levels, uptake and distribution of choline and DHA.

This study is designed to inform larger studies evaluating this approach of enteral co-application of choline and DHA on clinical important outcomes.

Full description

In utero, there is a constant high supply of choline to the fetus. Preterm delivery disrupts this maternal-fetal choline-transfer. We have shown that choline plasma levels rapidly half after preterm delivery. We also demonstrated that plasma DHA-PC rapidly falls after preterm delivery. DHA supplementation has been evaluated and found safe, however the clinical benefits have been smaller than expected. We speculate that choline deficiency may have contributed to the smaller than expected benefit of DHA supplementation in the past.

This study verifies the hypothesis that concomitant supply of choline and DHA will improve DHA-PC availability and turn-over. This is important because DHA-PC is the transport molecule for the DHA transport to the brain and the retina.

To explore the effects of enteral choline and DHA supplementation on plasma choline and DHA-PC concentrations, this randomized controlled study will assign 40 preterm infants to 1 of 4 groups: standard care, choline supplementation, DHA supplementation, and choline and DHA supplementation.

After 7 days of supplementation, a single dose of stable isotope labelled choline will be administered and the kinetics of newly synthesized DHA-PC determined to assess plasma levels, uptake and distribution of choline and DHA.

This study is designed to inform future larger studies evaluating this approach of enteral co-application of choline and DHA on important clinical outcomes.

Enrollment

24 patients

Sex

All

Ages

1 week to 2 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • preterm infants with a gestational age at birth between 24 and 32 weeks
  • on almost complete enteral feeding (>75% of total fluid intake)

Exclusion criteria

  • insufficient enteral intake,
  • gastrointestinal disease,
  • missing parental consent

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

24 participants in 4 patient groups

standard nutrition
Active Comparator group
Description:
standard nutrition
Treatment:
Dietary Supplement: standard nutrition
choline supplementation
Experimental group
Description:
in addition to standard nutrition: enteral supplementation with 30mg/kg choline chloride for 10 days
Treatment:
Dietary Supplement: standard nutrition
Dietary Supplement: choline supplementation
DHA supplementation
Experimental group
Description:
in addition to standard nutrition: enteral supplementation with 60mg/kg DHA for 10 days
Treatment:
Dietary Supplement: standard nutrition
Dietary Supplement: DHA supplementation
choline and DHA supplementation
Experimental group
Description:
in addition to standard nutrition: enteral supplementation with 30mg/kg choline chloride and 60mg/kg of DHA for 10 days
Treatment:
Dietary Supplement: standard nutrition
Dietary Supplement: choline supplementation
Dietary Supplement: DHA supplementation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems